Rare Disease Drug Market Report

China Rare Disease Drug Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：165
  • REPORT CODE：GMM1805087
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Rare disease drugs refer to the drugs that are used for rare diseases or have little commercial value, and no pharmaceutical company is willing to invest in the development of drugs. The definition of rare diseases is defined as 5/10000 of patients with less than 200 thousand patients or less than the incidence rate. There are 5000-6000 kinds of rare diseases, accounting for about 10% of human diseases.

    This report elaborates on the current development of the Rare Disease Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Alexion Pharmaceuticals, Inc

    • Novartis AG

    • Shire

    • Eisai Co, Ltd

    • Deciphera

    • Atara Biotherapeutics

    • Novo Nordisk A/S

    • Amgen, Inc

    • Pfizer, Inc

    • AstraZeneca

    • Johnson & Johnson

    • Celgene Corporation

    • Bristol-Myers Squibb Company

    • F Hoffmann-La Roche Ltd

    • Merck & Co, Inc

    • Daiichi Sankyo Company Limited

    • Biogen, Inc

    • Bayer AG

    • ProQR

    By Type:

    • <01%

    • 065%~1%

    • >1%

    By Application:

    • Retail pharmacies

    • Hospital Pharmacies

    • Speciality Pharmacies

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Rare Disease Drug Market Overview 2018-2029

    • 1.1 China Rare Disease Drug Industry Development Overview

    • 1.2 China Rare Disease Drug Industry Development History

    • 1.3 China Rare Disease Drug Industry Market Size (2018-2029)

    • 1.4 China Rare Disease Drug Market Analysis by Type from Production Side

      • 1.4.1 China Rare Disease Drug Production Volume, Production Value and Growth Rate of <01% (2018-2029)

      • 1.4.2 China Rare Disease Drug Production Volume, Production Value and Growth Rate of 065%~1% (2018-2029)

      • 1.4.3 China Rare Disease Drug Production Volume, Production Value and Growth Rate of >1% (2018-2029)

    • 1.5 China Rare Disease Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Rare Disease Drug Sales Volume, Sales Value and Growth Rate of Retail pharmacies (2018-2029)

      • 1.5.2 China Rare Disease Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

      • 1.5.3 China Rare Disease Drug Sales Volume, Sales Value and Growth Rate of Speciality Pharmacies (2018-2029)

      • 1.5.4 China Rare Disease Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Rare Disease Drug Market Analysis by Region

      • 1.6.1 North China Rare Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Rare Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Rare Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Rare Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Rare Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Rare Disease Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Rare Disease Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Rare Disease Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Rare Disease Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Rare Disease Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Rare Disease Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Rare Disease Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Rare Disease Drug Industry Development

    Chapter 3 Rare Disease DrugIndustry Chain Analysis

    • 3.1 Rare Disease Drug Industry Chain

    • 3.2 Rare Disease Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Rare Disease Drug Market

    • 3.3 Rare Disease Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Rare Disease Drug Market

    Chapter 4 China Rare Disease Drug Market, by Type

    • 4.1 China Rare Disease Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Rare Disease Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Rare Disease Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Rare Disease Drug Production Volume and Growth Rate of <01%

      • 4.5.2 China Rare Disease Drug Production Volume and Growth Rate of 065%~1%

      • 4.5.3 China Rare Disease Drug Production Volume and Growth Rate of >1%

    Chapter 5 China Rare Disease Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Rare Disease Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Rare Disease Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Rare Disease Drug Market Size and Growth Rate of Retail pharmacies

      • 5.5.2 China Rare Disease Drug Market Size and Growth Rate of Hospital Pharmacies

      • 5.5.3 China Rare Disease Drug Market Size and Growth Rate of Speciality Pharmacies

      • 5.5.4 China Rare Disease Drug Market Size and Growth Rate of Others

    Chapter 6 China Rare Disease Drug Market, by Region

    • 6.1 China Rare Disease Drug Production Volume and Production Value, by Region

    • 6.2 China Rare Disease Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Rare Disease Drug Market Analysis

    • 7.1 North China Rare Disease Drug Market, by Type

    • 7.2 North China Rare Disease Drug Market, by Application

    Chapter 8 Central China Rare Disease Drug Market Analysis

    • 8.1 Central China Rare Disease Drug Market, by Type

    • 8.2 Central China Rare Disease Drug Market, by Application

    Chapter 9 South China Rare Disease Drug Market Analysis

    • 9.1 South China Rare Disease Drug Market, by Type

    • 9.2 South China Rare Disease Drug Market, by Application

    Chapter 10 East China Rare Disease Drug Market Analysis

    • 10.1 East China Rare Disease Drug Market, by Type

    • 10.2 East China Rare Disease Drug Market, by Application

    Chapter 11 Northeast China Rare Disease Drug Market Analysis

    • 11.1 Northeast China Rare Disease Drug Market, by Type

    • 11.2 Northeast China Rare Disease Drug Market, by Application

    Chapter 12 Southwest China Rare Disease Drug Market Analysis

    • 12.1 Southwest China Rare Disease Drug Market, by Type

    • 12.2 Southwest China Rare Disease Drug Market, by Application

    Chapter 13 Northwest China Rare Disease Drug Market Analysis

    • 13.1 Northwest China Rare Disease Drug Market, by Type

    • 13.2 Northwest China Rare Disease Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Alexion Pharmaceuticals, Inc

        • 14.1.1 Alexion Pharmaceuticals, Inc Company Profile

        • 14.1.2 Alexion Pharmaceuticals, Inc Rare Disease Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Novartis AG

        • 14.2.1 Novartis AG Company Profile

        • 14.2.2 Novartis AG Rare Disease Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Shire

        • 14.3.1 Shire Company Profile

        • 14.3.2 Shire Rare Disease Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eisai Co, Ltd

        • 14.4.1 Eisai Co, Ltd Company Profile

        • 14.4.2 Eisai Co, Ltd Rare Disease Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Deciphera

        • 14.5.1 Deciphera Company Profile

        • 14.5.2 Deciphera Rare Disease Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Atara Biotherapeutics

        • 14.6.1 Atara Biotherapeutics Company Profile

        • 14.6.2 Atara Biotherapeutics Rare Disease Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novo Nordisk A/S

        • 14.7.1 Novo Nordisk A/S Company Profile

        • 14.7.2 Novo Nordisk A/S Rare Disease Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Amgen, Inc

        • 14.8.1 Amgen, Inc Company Profile

        • 14.8.2 Amgen, Inc Rare Disease Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Pfizer, Inc

        • 14.9.1 Pfizer, Inc Company Profile

        • 14.9.2 Pfizer, Inc Rare Disease Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 AstraZeneca

        • 14.10.1 AstraZeneca Company Profile

        • 14.10.2 AstraZeneca Rare Disease Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Johnson & Johnson

        • 14.11.1 Johnson & Johnson Company Profile

        • 14.11.2 Johnson & Johnson Rare Disease Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Celgene Corporation

        • 14.12.1 Celgene Corporation Company Profile

        • 14.12.2 Celgene Corporation Rare Disease Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Bristol-Myers Squibb Company

        • 14.13.1 Bristol-Myers Squibb Company Company Profile

        • 14.13.2 Bristol-Myers Squibb Company Rare Disease Drug Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 F Hoffmann-La Roche Ltd

        • 14.14.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.14.2 F Hoffmann-La Roche Ltd Rare Disease Drug Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Merck & Co, Inc

        • 14.15.1 Merck & Co, Inc Company Profile

        • 14.15.2 Merck & Co, Inc Rare Disease Drug Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Daiichi Sankyo Company Limited

        • 14.16.1 Daiichi Sankyo Company Limited Company Profile

        • 14.16.2 Daiichi Sankyo Company Limited Rare Disease Drug Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Biogen, Inc

        • 14.17.1 Biogen, Inc Company Profile

        • 14.17.2 Biogen, Inc Rare Disease Drug Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Bayer AG

        • 14.18.1 Bayer AG Company Profile

        • 14.18.2 Bayer AG Rare Disease Drug Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 ProQR

        • 14.19.1 ProQR Company Profile

        • 14.19.2 ProQR Rare Disease Drug Market Performance

        • 14.19.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Rare Disease Drug Industry Research Conclusions

    • 15.2 Rare Disease Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Rare Disease Drug Industry Market Size (2018-2029)

    • Figure China Rare Disease Drug Production Volume, Production Value and Growth Rate of <01% (2018-2029)

    • Figure China Rare Disease Drug Production Volume, Production Value and Growth Rate of 065%~1% (2018-2029)

    • Figure China Rare Disease Drug Production Volume, Production Value and Growth Rate of >1% (2018-2029)

    • Figure China Rare Disease Drug Sales Volume, Sales Value and Growth Rate of Retail pharmacies (2018-2029)

    • Figure China Rare Disease Drug Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)

    • Figure China Rare Disease Drug Sales Volume, Sales Value and Growth Rate of Speciality Pharmacies (2018-2029)

    • Figure China Rare Disease Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Rare Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Rare Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Rare Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Rare Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Rare Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Rare Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Rare Disease Drug Market Size and Growth Rate from 2018-2029

    • Figure Rare Disease Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Rare Disease Drug Market Share by Type in 2018

    • Figure China Rare Disease Drug Market Share by Type in 2023

    • Figure China Rare Disease Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Rare Disease Drug Production Volume and Growth Rate of <01% (2018-2023)

    • Figure China Rare Disease Drug Production Volume and Growth Rate of 065%~1% (2018-2023)

    • Figure China Rare Disease Drug Production Volume and Growth Rate of >1% (2018-2023)

    • Figure China Rare Disease Drug Market Share by Application in 2018

    • Figure China Rare Disease Drug Market Share by Application in 2023

    • Figure China Rare Disease Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Rare Disease Drug Market Size and Growth Rate of Retail pharmacies (2018-2023)

    • Figure China Rare Disease Drug Market Size and Growth Rate of Hospital Pharmacies (2018-2023)

    • Figure China Rare Disease Drug Market Size and Growth Rate of Speciality Pharmacies (2018-2023)

    • Figure China Rare Disease Drug Market Size and Growth Rate of Others (2018-2023)

    • Table China Rare Disease Drug Production Volume by Region (2018-2023)

    • Table China Rare Disease Drug Production Volume Share by Region (2018-2023)

    • Figure China Rare Disease Drug Production Volume Share by Region (2018-2023)

    • Table China Rare Disease Drug Production Value by Region (2018-2023)

    • Table China Rare Disease Drug Production Value Share by Region (2018-2023)

    • Figure China Rare Disease Drug Production Value Share by Region (2018-2023)

    • Table China Rare Disease Drug Sales Volume by Region (2018-2023)

    • Table China Rare Disease Drug Sales Volume Share by Region (2018-2023)

    • Figure China Rare Disease Drug Sales Volume Share by Region (2018-2023)

    • Table China Rare Disease Drug Sales Value by Region (2018-2023)

    • Table China Rare Disease Drug Sales Value Share by Region (2018-2023)

    • Figure China Rare Disease Drug Sales Value Share by Region (2018-2023)

    • Table North China Rare Disease Drug Production Volume by Type (2018-2023)

    • Table North China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Figure North China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Table North China Rare Disease Drug Sales Volume by Application (2018-2023)

    • Table North China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Rare Disease Drug Production Volume by Type (2018-2023)

    • Table Central China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Table Central China Rare Disease Drug Sales Volume by Application (2018-2023)

    • Table Central China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Table South China Rare Disease Drug Production Volume by Type (2018-2023)

    • Table South China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Figure South China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Table South China Rare Disease Drug Sales Volume by Application (2018-2023)

    • Table South China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Table East China Rare Disease Drug Production Volume by Type (2018-2023)

    • Table East China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Figure East China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Table East China Rare Disease Drug Sales Volume by Application (2018-2023)

    • Table East China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Rare Disease Drug Production Volume by Type (2018-2023)

    • Table Northeast China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Rare Disease Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Rare Disease Drug Production Volume by Type (2018-2023)

    • Table Southwest China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Rare Disease Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Rare Disease Drug Production Volume by Type (2018-2023)

    • Table Northwest China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Rare Disease Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Rare Disease Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Rare Disease Drug Sales Volume Share by Application (2018-2023)

    • Table Alexion Pharmaceuticals, Inc Company Profile

    • Table Alexion Pharmaceuticals, Inc Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Shire Company Profile

    • Table Shire Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Eisai Co, Ltd Company Profile

    • Table Eisai Co, Ltd Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Deciphera Company Profile

    • Table Deciphera Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Atara Biotherapeutics Company Profile

    • Table Atara Biotherapeutics Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk A/S Company Profile

    • Table Novo Nordisk A/S Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Amgen, Inc Company Profile

    • Table Amgen, Inc Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo Company Limited Company Profile

    • Table Daiichi Sankyo Company Limited Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Biogen, Inc Company Profile

    • Table Biogen, Inc Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Rare Disease Drug Revenue, Price and Gross (2018-2023)

    • Table ProQR Company Profile

    • Table ProQR Rare Disease Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US